Literature DB >> 24311773

Experimental rhinovirus 16 infection in moderate asthmatics on inhaled corticosteroids.

Peter T Adura1, Eleanor Reed, Jonathan Macintyre, Ajerico Del Rosario, James Roberts, Rachel Pestridge, Rona Beegan, Christine B Boxall, Chang Xiao, Tatiana Kebadze, Juliya Aniscenko, Victoria Cornelius, James E Gern, Phillip D Monk, Sebastian L Johnston, Ratko Djukanović.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24311773     DOI： 10.1183/09031936.00141713

Source DB:  PubMed          Journal:  Eur Respir J        ISSN： 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  11 in total

1.  Rhinovirus C15 Induces Airway Hyperresponsiveness via Calcium Mobilization in Airway Smooth Muscle.

Authors:  Vishal Parikh; Jacqueline Scala; Riva Patel; Corinne Corbi; Dennis Lo; Yury A Bochkov; Joshua L Kennedy; Richard C Kurten; Stephen B Liggett; James E Gern; Cynthia J Koziol-White
Journal:  Am J Respir Cell Mol Biol       Date:  2020-03       Impact factor: 6.914

Review 2.  Rhinovirus and Asthma Exacerbations.

Authors:  Joshua L Kennedy; Sarah Pham; Larry Borish
Journal:  Immunol Allergy Clin North Am       Date:  2019-05-15       Impact factor: 3.479

Review 3.  Rhinovirus Attributes that Contribute to Asthma Development.

Authors:  Mingyuan Han; Charu Rajput; Marc B Hershenson
Journal:  Immunol Allergy Clin North Am       Date:  2019-05-07       Impact factor: 3.479

4.  A Tool for Investigating Asthma and COPD Exacerbations: A Newly Manufactured and Well Characterised GMP Wild-Type Human Rhinovirus for Use in the Human Viral Challenge Model.

Authors:  Daniel J Fullen; Bryan Murray; Julie Mori; Andrew Catchpole; Daryl W Borley; Edward J Murray; Ganesh Balaratnam; Anthony Gilbert; Alex Mann; Fiona Hughes; Rob Lambkin-Williams
Journal:  PLoS One       Date:  2016-12-09       Impact factor: 3.240

5.  Rhinovirus infection results in stronger and more persistent genomic dysregulation: Evidence for altered innate immune response in asthmatics at baseline, early in infection, and during convalescence.

Authors:  Peter W Heymann; Huyen-Tran Nguyen; John W Steinke; Ronald B Turner; Judith A Woodfolk; Thomas A E Platts-Mills; Lisa Martin; Hua He; Jocelyn Biagini Myers; Mark Lindsey; Umasundari Sivaprasad; Mario Medvedovic; Naim Mahi; Holliday Carper; Deborah D Murphy; James Patrie; Gurjit K Khurana Hershey
Journal:  PLoS One       Date:  2017-05-26       Impact factor: 3.240

6.  Influence of viral infection on the relationships between airway cytokines and lung function in asthmatic children.

Authors:  Toby C Lewis; Ediri E Metitiri; Graciela B Mentz; Xiaodan Ren; Ashley R Carpenter; Adam M Goldsmith; Kyra E Wicklund; Breanna N Eder; Adam T Comstock; Jeannette M Ricci; Sean R Brennan; Ginger L Washington; Kendall B Owens; Bhramar Mukherjee; Thomas G Robins; Stuart A Batterman; Marc B Hershenson
Journal:  Respir Res       Date:  2018-11-21

Review 7.  Utility of animal and in vivo experimental infection of humans with rhinoviruses in the development of therapeutic agents for viral exacerbations of asthma and chronic obstructive pulmonary disease.

Authors:  Alfred M Del Vecchio; Patrick J Branigan; Elliot S Barnathan; Susan K Flavin; Philip E Silkoff; Ronald B Turner
Journal:  Pulm Pharmacol Ther       Date:  2014-11-13       Impact factor: 3.410

8.  Rhinovirus-16 induced temporal interferon responses in nasal epithelium links with viral clearance and symptoms.

Authors:  Abilash Ravi; Meiping Chang; Marianne van de Pol; Shan Yang; Antonios Aliprantis; Bob Thornton; Leonidas N Carayannopoulos; An Bautmans; Martine Robberechts; Inge De Lepeleire; Dave Singh; Jens M Hohlfeld; Peter J Sterk; Norbert Krug; René Lutter
Journal:  Clin Exp Allergy       Date:  2019-10-31       Impact factor: 5.018

9.  Inducible epithelial resistance against acute Sendai virus infection prevents chronic asthma-like lung disease in mice.

Authors:  David L Goldblatt; Jose R Flores; Gabriella Valverde Ha; Ana M Jaramillo; Sofya Tkachman; Carson T Kirkpatrick; Shradha Wali; Belinda Hernandez; David E Ost; Brenton L Scott; Jichao Chen; Scott E Evans; Michael J Tuvim; Burton F Dickey
Journal:  Br J Pharmacol       Date:  2020-02-12       Impact factor: 9.473

Review 10.  Repurposing Existing Drugs for the Treatment of COVID-19.

Authors:  Hugo Farne; Kartik Kumar; Andrew I Ritchie; Lydia J Finney; Sebastian L Johnston; Aran Singanayagam
Journal:  Ann Am Thorac Soc       Date:  2020-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.